Stay updated on Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial page.

Latest updates to the Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA new version entry dated 2024-11-27 appears in the record history, showing updated study and recruitment status for NCT05560399. This reflects ongoing updates to the trial's official status on ClinicalTrials.gov.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check41 days agoChange Detected- Added a government funding lapse notice and current operating status guidance for NIH Clinical Center, and a version bump to v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference12%

- Check48 days agoChange DetectedUpdates the page version from v3.0.2 to v3.1.0, indicating a new release tag without changing core content.SummaryDifference0.3%

- Check62 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2, indicating a new release; the 'Back to Top' link was removed, representing a minor navigation change with no substantive content updates.SummaryDifference0.7%

- Check69 days agoChange DetectedThe web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.7%

- Check77 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, while several location-related terms have been removed.SummaryDifference12%

Stay in the know with updates to Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial page.